Figs (NYSE: FIGS), which went public just about a year ago last May, was one of 2021's hottest IPOs. But 2022 hasn't been kind to the healthcare apparel maker as it is now down 80% from its 52-week high and down nearly 70% year to date.
Figs has declined because of the same issues that are affecting the broader market, including inflation and supply-chain concerns, as well as the fact that it lowered its earnings and sales guidance on its latest earnings call. But Figs still has many of the hallmarks of a good, long-term investment.
Here are the top three reasons I view Figs as a buy at these levels.
Source Fool.com